BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6169783)

  • 1. Antigenic and structural relatedness among non-capsid and capsid polypeptides of polioviruses belonging to different serotypes.
    Romanova LI; Tolskaya EA; Agol VI
    J Gen Virol; 1981 Feb; 52(Pt 2):279-89. PubMed ID: 6169783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
    Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
    J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intertypic antigenic determinants of intracellular proteins of different poliovirus serotypes].
    Romanova LI; Tol'skaia EA; Agol VI
    Vopr Virusol; 1980; (5):570-3. PubMed ID: 6159736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenicity and immunogenicity of poliovirus capsid proteins.
    van Wezel AL; van der Marel P; Hazendonk TG; Boer-Bak V; Henneke MA
    Dev Biol Stand; 1983; 55():209-15. PubMed ID: 6203795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
    Wiegers KJ; Dernick R
    J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.
    Uhlig H; Haardt F; Dernick R
    Arch Virol; 1985; 83(3-4):295-303. PubMed ID: 2578787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for conformational changes of poliovirus precursor particles during virus morphogenesis.
    Wiegers KJ; Dernick R
    J Gen Virol; 1985 May; 66 ( Pt 5)():1037-44. PubMed ID: 2582079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide.
    Crainic R; Blondel B; Horaud F
    Dev Biol Stand; 1983; 55():185-9. PubMed ID: 6329856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoelectric points of polypeptides of standard poliovirus particles of different serological types and of empty capsids and dense particles of poliovirus type 1.
    Hamann A; Reichel C; Wiegers KJ; Drzeniek R
    J Gen Virol; 1978 Mar; 38(3):567-70. PubMed ID: 204736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intertypic cross-reactions of nonneutralizing, monoclonal poliovirus antibodies.
    Vrijsen R; Rombaut B; Boeye A
    J Virol; 1984 Mar; 49(3):1002-4. PubMed ID: 6199509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four independent antigenic determinants on the capsid polypeptides of aphthovirus.
    Haresnape JM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2345-55. PubMed ID: 6196438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsid polypeptides of virulent and attenuated strains of the three poliovirus serotypes [proceedings].
    Vrijsen R; BoeyƩ A
    Arch Int Physiol Biochim; 1978 May; 86(2):468-9. PubMed ID: 81035
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.
    van der Marel P; Hazendonk TG; Henneke MA; van Wezel AL
    Vaccine; 1983 Dec; 1(1):17-22. PubMed ID: 6099638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intertypic recombination in poliovirus: genetic and biochemical studies.
    Tolskaya EA; Romanova LA; Kolesnikova MS; Agol VI
    Virology; 1983 Jan; 124(1):121-32. PubMed ID: 6297149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones.
    Mahon BP; Katrak K; Mills KH
    J Virol; 1992 Dec; 66(12):7012-20. PubMed ID: 1279196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and antigenic variation of the structural protein VP3 in serotype 1 poliovirus isolated from vaccinees.
    Cash P
    Can J Microbiol; 1988 Jun; 34(6):802-6. PubMed ID: 2849500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rotaviruses: structure and function of the principal polypeptides].
    Vautherot-Chabanne D
    Ann Rech Vet; 1989; 20(4):431-42. PubMed ID: 2559646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.